Olanzapine
Product Images NDC 64725-3159

2 FDA label images from Tya Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 64725-3159). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tya Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (1e9666ef 4271 4834 8496 Ccb3125d83db 01)

Structural Formula (1e9666ef 4271 4834 8496 Ccb3125d83db 01)
Chemical structure of Olanzapine showing its molecular framework with a thienobenzodiazepine core, including nitrogen, sulfur atoms, and methyl groups as visible in the diagram.*
FDA Label Image

Label Image (64725 3159)

Label Image (64725 3159)
A label for Olanzapine (Zyprexa) injection, 10 mg/mL. It indicates Rx only, with placeholder lot and expiration dates. Manufactured by Gland Pharma Ltd and repackaged by T.Y.A. Pharmaceuticals, located in Tallahassee, FL. The label includes a barcode and directs to see package insert for dosing information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.